Newsroom | Top Stories | Abbott U.S.
Jun 10, 2024 · Innovating for a Healthier, Sustainable Future. Abbott's Global Sustainability Report shares how we're focused on helping more people, now and in the years ahead. SEE MORE. An overview of our business, including our financial profile and public honors.
Abbott MediaRoom - Press Releases
Oct 10, 2024 · Abbott Expands its Pure Bliss™ Line of Infant Formulas to Include European-Made and Organic Products; Offers the First and Only Organic Liquid Formula Available at U.S. Retail Stores. Aug 21, 2024.
Abbott Receives U.S. FDA Clearance for Two New Over-the …
ABBOTT PARK, Ill., June 10, 2024 / PRNewswire / -- Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) systems – Lingo™ and Libre Rio™, which are based on Abbott's world-leading FreeStyle Libre® continuous glucose monitoring technology 1, now used b...
Abbott shares rise after securing first win in premature infant …
Nov 1 (Reuters) - Abbott Laboratories (ABT.N) shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their premature ...
Abbott Laboratories (ABT) Latest Stock News & Headlines
Get the latest Abbott Laboratories (ABT) stock news and headlines to help you in your trading and investing decisions.
Abbott Reports Fourth-Quarter and Full-Year 2023 ... - Abbott …
ABBOTT PARK, Ill., Jan. 24, 2024 /PRNewswire/ -- Abbott today announced financial results for the fourth quarter ended Dec. 31, 2023. Fourth-quarter sales increased 1.5 percent on a reported basis, 2.1 percent on an organic basis, and 11.0 percent on an organic basis, excluding COVID-19 testing-related sales 1 .
Abbott’s Q4 Earnings Sustain Momentum Into 2024
Jan 24, 2024 · Sales for the fourth quarter of 2023 reached $10.2 billion, an 11.0% organic increase, excluding COVID-19 testing-related revenue, driven by Medical Devices (up 15.4% organic; 17.5% reported) and Nutrition (up 13.9% organic; 12.2% reported).
Abbott Q3 Continues Underlying Base Business Growth | Abbott …
Oct 18, 2023 · The company has now reported three consecutive quarters of double-digit organic growth in the underlying base business 2, driven by investments made during the pandemic. Global sales for the third quarter were $10.1 billion, reflecting organic sales growth for the underlying base business of 13.8%.
Abbott Labs shines with a strong quarter and a buyback …
Oct 16, 2024 · Medical device maker Abbott Laboratories on Wednesday delivered better-than-expected quarterly results and upped its earnings guidance for the third straight quarter. Shares rose more than 1%,...
After baby formula problems, Abbott Laboratories under DOJ ... - NBC News
Jan 21, 2023 · Abbott Laboratories is under investigation by the U.S. Department of Justice, the company confirmed Friday, almost a year after it shut down a Michigan baby-formula plant after illnesses were...